Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pierre Robin Sequence Outcome Assessment Multi Institutional Study (PROMIS)

NCT02432638 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02432638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02432638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pierre Robin Sequence Outcome Assessment Multi Institutional Study (PROMIS)
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Withdrawn
Start date
April 30, 2015
Completion date
October 27, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pierre robin sequence